Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
397.7 USD | -0.76% | +1.07% | -2.26% |
Apr. 25 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $497 From $515 | MT |
Apr. 23 | Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B | |
-26.18% | 8.08B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals Incorporated Revises Revenue Guidance for the Year 2021